top of page
This series is designed to provide investors with context to press releases directly from company management teams. It also provides the opportunity for companies to communicate directly to investors and elaborate on recent key news and highlight value driving milestones.
September 27, 2023
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement.
September 8, 2023
AREC"s ReElement Technologies Expands Executive Team
August 24, 2023
Recent Clinical Update on Potentially Pivotal Study of Berubicin for GBM
GRI Bio Enters into Asset Purchase Agreement for Sale of Legacy Asset, ADAIR
August 23, 2023
August 7, 2023
GRI Bio Presents Encouraging Preclinical Data of GRI-0803 in Lupus Nephritis
Access, Ideas, Clarity
A leading virtual platform providing investors with direct access to innovative companies, management teams and thought leaders
What This Means:
Contat Us
bottom of page